Journal
ADVANCED DRUG DELIVERY REVIEWS
Volume 146, Issue -, Pages 97-125Publisher
ELSEVIER
DOI: 10.1016/j.addr.2018.09.010
Keywords
Wound healing; Angiogenesis; Growth factor therapy; Cell-based therapies; Stem cell therapy; Neovascularization; Diabetic ulcers; Chronic wounds; Non-healing wounds
Categories
Funding
- American Heart Association [17IRG33410888]
- DOD CDMRP [W81XWH-16-1-0580, W81XWH-16-1-0582]
- National Institutes of Health [1R21EB023551-01, 1R21EB024147-01A1, 1R01HL141761-01]
- NSF [DGE-1610403]
Ask authors/readers for more resources
The enhancement of wound healing has been a goal of medical practitioners for thousands of years. The development of chronic, non-healing wounds is a persistent medical problem that drives patient morbidity and increases healthcare costs. A key aspect of many non-healing wounds is the reduced presence of vessel growth through the process of angiogenesis. This review surveys the creation of new treatments for healing cutaneous wounds through therapeutic angiogenesis. In particular, we discuss the challenges and advancement that have been made in delivering biologic, pharmaceutical and cell-based therapies as enhancers of wound vascularity and healing. (C) 2018 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available